Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.
Sala, E
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas. [electronic resource] - Journal of endocrinological investigation Dec 2016 - 1377-1382 p. digital
Publication Type: Journal Article
1720-8386
10.1007/s40618-016-0483-z doi
Adult
Aged
Biomarkers--blood
Cabergoline
Dopamine Agonists--therapeutic use
Ergolines--therapeutic use
Female
Humans
Hyperprolactinemia--diagnosis
Male
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Pituitary Neoplasms--complications
Prognosis
Prolactinoma--complications
Tomography, X-Ray Computed--methods
Withholding Treatment
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas. [electronic resource] - Journal of endocrinological investigation Dec 2016 - 1377-1382 p. digital
Publication Type: Journal Article
1720-8386
10.1007/s40618-016-0483-z doi
Adult
Aged
Biomarkers--blood
Cabergoline
Dopamine Agonists--therapeutic use
Ergolines--therapeutic use
Female
Humans
Hyperprolactinemia--diagnosis
Male
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Pituitary Neoplasms--complications
Prognosis
Prolactinoma--complications
Tomography, X-Ray Computed--methods
Withholding Treatment